| Literature DB >> 36071970 |
Wenjing Chen1,2,3, Ruxin Guo1,2, Zhigang Wang1,2, Weihui Xu1,2, Yunlong Hu1,2.
Abstract
A Gram-negative bacteria (Pseudomonas fluorescens) was exposed to different concentrations (0, 20, and 40 mg/L) of dimethyl phthalate (DMP) for 8 h, and then Fourier transform infrared spectroscopy (FTIR) analysis, lipopolysaccharide content detection, analysis of fatty acids, calcein release test, proteomics, non-targeted metabolomics, and enzyme activity assays were used to evaluate the toxicological effect of DMP on P. fluorescens. The results showed that DMP exposure caused an increase in the unsaturated fatty acid/saturated fatty acid (UFA/SFA) ratio and in the release of lipopolysaccharides (LPSs) from the cell outer membrane (OM) of P. fluorescens. Moreover, DMP regulated the abundances of phosphatidyl ethanolamine (PE) and phosphatidyl glycerol (PG) of P. fluorescens and induced dye leakage from an artificial membrane. Additionally, excessive reactive oxygen species (ROS), malondialdehyde (MDA), and changes in antioxidant enzymes (i.e., catalase [CAT] and superoxide dismutase [SOD]) activities, as well as the inhibition of Ca2+-Mg2+-ATPase and Na+/K+-ATPase activities in P. fluorescens, which were induced by the DMP. In summary, DMP could disrupt the lipid asymmetry of the outer membrane, increase the fluidity of the cell membrane, and destroy the integrity of the cell membrane of P. fluorescens through lipid peroxidation, oxidative stress, and ion imbalance.Entities:
Keywords: Pseudomonas fluorescens; cell micro-interface; dimethyl phthalate; oxidative stress; toxicological effect
Year: 2022 PMID: 36071970 PMCID: PMC9441906 DOI: 10.3389/fmicb.2022.949590
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
Figure 1Effects of dimethyl phthalate (DMP) on the cell surface functional groups, lipopolysaccharide (LPS) transporter and LPS content of Pseudomonas fluorescens (P. fluorescens). (A) shows DMP changed the cell surface functional groups; (B) shows that DMP increased the expression of LPS export ATP-binding cassette (ABC) transporter ATP-binding protein abundance through proteomics, and (C) shows LPS content of P. fluorescens. Different letters represent significant differences between treatments.
Figure 2The expression of proteins in the fatty acid metabolism pathway and the ratio of UFA/SFA of P. fluorescens were altered by DMP contamination. (A) shows that DMP inhibited the expression of long-chain acyl-CoA dehydrogenase abundance through proteomics, and (B) shows that the ratio of UFA/SFA of P. fluorescens was changed by DMP treatment. Different letters represent significant differences between treatments.
Figure 3The effect of DMP on the phospholipid and integrity of cell membrane of the P. fluorescens. (A) indicates that DMP inhibited the expression of outer membrane (OM) lipid asymmetry maintenance protein abundance through proteomics; (B,C) indicate that the abundance of phosphatidyl ethanolamine (PE) and phosphatidyl glycerol (PG) were decreased by DMP treatment through metabolomics; (D) indicates that the integrity of the cell membrane of P. fluorescens was changed by DMP treatment by the calcein release test. Different letters represent significant differences between treatments.
Figure 4The effect of DMP on the oxidative-reactive kinase system of the P. fluorescens. (A) indicates that DMP inhibited the expression of catalase abundance through proteomics; (B,E) show the activities of catalase (CAT) (B) and superoxide dismutase (SOD) (E) of P. fluorescens was changed by DMP treatment; (C,D) show reactive oxygen species (ROS) and malondialdehyde (MDA). Different letters represent significant differences between treatments.
Figure 5The effect of DMP on key enzymes on the cell membrane of the P. fluorescens. (A) indicates that DMP inhibited the expression of K+-transporting ATPase abundance through proteomics; (B,C) indicate that the activities of Na+-K+-ATPase and Ca2+-Mg2+-ATPase of P. fluorescens were changed by DMP treatment. Different letters represent significant differences between treatments.